CurrentCardio
Get Weekly

Topic · page 21 of 34

Arrhythmias & electrophysiology

AF (incl. stroke prevention and anticoagulation in AF), ventricular arrhythmias, sudden death prevention, pacing and conduction, ablation, syncope

Briefs 801–840 of 1,350 placed here, newest publication first

Briefs in Arrhythmias & electrophysiology

Newest publication first

  1. J Am Coll Cardiol

    Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants

    Meta-analysis

  2. JACC Cardiovasc Imaging

    Outcomes of Left Atrial Appendage Patency After Device Closure Detected by Cardiac CT: A Meta-Analysis

    Meta-analysis

  3. Europace

    Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: a systematic review and meta-analysis

    Meta-analysis

  4. Eur J Prev Cardiol

    Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

    Cohort study

  5. JAMA Cardiol

    Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical Trial

    Secondary analysis

  6. JAMA Cardiol

    Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy

    Cohort study

  7. Europace

    Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry

    Cohort study

  8. Europace

    Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

    Randomised controlled trial

  9. Circulation

    Biomarker-Based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation: A Registry-Based, Multicenter, Randomized, Controlled Study

    Randomised controlled trial

  10. Eur Heart J

    Hypokalaemia and atrial fibrillation detected by implanted loop recorders

    Secondary analysis

  11. Eur Heart J

    Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial

    Randomised controlled trial

  12. N Engl J Med

    Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias

    Randomised controlled trial

  13. Eur Heart J

    Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging

    Cross-sectional study

  14. Europace

    Atrial fibrillation burden and symptom, quality of life, and healthcare resource utilization after cryoballoon ablation in persistent atrial fibrillation

    Secondary analysis

  15. Europace

    Impact of timing of treatment for cardiac implantable electronic device infections on healthcare utilization and expenditures

    Cohort study

  16. Europace

    Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis

    Meta-analysis

  17. Eur Heart J

    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study

    Cohort study

  18. J Am Coll Cardiol

    Clinical Outcomes of Conduction System Pacing vs Right Ventricular Septal Pacing in Atrioventricular Block: The CSPACE Randomized Controlled Trial

    Randomised controlled trial

  19. Europace

    Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden

    Cohort study

  20. Europace

    Incidence of laboratory-defined severe intravascular haemolysis across commercially available pulsed field ablation technologies for atrial fibrillation

    Cohort study

  21. Europace

    Systematic, randomised atrial fibrillation screening using detailed phenotyping with a risk-prediction model combined with patch electrocardiogram in a Swedish population aged 65 years or older: The CONSIDERING-AF trial

    Randomised controlled trial

  22. Europace

    Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram

    Cohort study

  23. Europace

    Impact of ventricular tachycardia ablation in the setting of electrical storm based on patient risk profile

    Cohort study

  24. Eur J Prev Cardiol

    Ethnic differences in clinical outcomes following major bleeding in atrial fibrillation patients: a report from two prospective regional registries in Europe and Asia

    Cohort study

  25. Europace

    Prevalence and relation to training of electrocardiographic findings in Caucasian children and adolescents 8- to 18-year-old practicing competitive sport

    Cross-sectional study

  26. Europace

    Pulmonary vein isolation with or without empiric superior vena cava isolation in patients undergoing ablation for paroxysmal atrial fibrillation: the randomized ESVCI-AF trial

    Randomised controlled trial

  27. Europace

    Circumferential pulmonary vein isolation with adjunctive linear ablation vs. circumferential pulmonary vein isolation alone for long-standing persistent atrial fibrillation: a randomized pilot study

    Randomised controlled trial

  28. Europace

    EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit

    Research article

  29. J Am Coll Cardiol

    Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy

    Meta-analysis

  30. J Am Coll Cardiol

    Using Compression Stockings to Prevent Recurrence of Vasovagal Syncope: A Randomized Sham-Controlled Trial

    Randomised controlled trial

  31. Europace

    Personalized pulmonary vein isolation guided by left atrial wall thickness for persistent atrial fibrillation ablation: the PeAF-by-LAWT randomized trial

    Randomised controlled trial

  32. Europace

    Regionalization of the atria for 3D electroanatomical mapping, cardiac imaging, and computational modelling: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Cardiovascular Imaging of the ESC

    Guideline or statement

  33. Europace

    Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study

    Cohort study

  34. Eur Heart J

    Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial

    Randomised controlled trial

  35. Eur J Prev Cardiol

    Sleeping and the risk of atrial fibrillation: a prospective study in the SUN cohort

    Cohort study

  36. Europace

    Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study

    Cohort study

  37. Europace

    Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders

    Cross-sectional study

  38. Europace

    Very high-power short-duration using 70W and a flexible tip ablation catheter for pulmonary vein isolation: the POWER PULSE randomized controlled trial

    Randomised controlled trial

  39. Eur J Heart Fail

    Fibrosis-4 Index Reflects the Severity of Tricuspid Regurgitation and Patient Prognosis in Atrial Fibrillation

    Cohort study

  40. Europace

    A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis

    Meta-analysis

All 1,350 Briefs in ExploreShowing Briefs 801–840 of 1,350, newest first